NINGBO INNO PHARMCHEM CO.,LTD. presents a detailed look into the chemical profile of Erlosamide (CAS 175481-36-4), a compound of significant value in the pharmaceutical industry. Understanding its distinct properties, such as its >98% purity and white powder form, is fundamental for its effective utilization in drug development, particularly for neurological applications.

Erlosamide, also known by its therapeutic name Lacosamide, is recognized for its crucial role in anticonvulsant therapies. Its mechanism of action centers on the selective enhancement of slow inactivation of voltage-gated sodium channels. This action is vital for stabilizing neuronal membranes and preventing the uncontrolled firing that leads to seizures. Pharmaceutical manufacturers often seek to buy Erlosamide for its proven efficacy in treating partial-onset seizures and its potential in managing neuropathic pain conditions, such as diabetic neuropathy.

The chemical and physical data associated with Erlosamide, including its molecular formula (C13H18N2O3) and molecular weight (250.29 g/mol), provide a clear blueprint for its integration into complex pharmaceutical formulations. The reliability of its properties ensures that research and manufacturing processes maintain high standards, essential for producing safe and effective medications. When considering the purchase of Erlosamide, the emphasis on consistent quality from suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is paramount.

The compound's journey from its synthesis to its current status as a key pharmaceutical intermediate is a testament to its therapeutic value. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the pharmaceutical sector by providing access to high-grade Erlosamide, facilitating the ongoing innovation in neurological health and pain management solutions.